Lamotrigine Teva

Lamotrigine, the active ingredient in Lamotrigine Teva, is a Anticonvulsant presented as an oral formulation for Oral use. It treats epilepsy, including partial and generalized tonic‑clonic seizures, and is used for maintenance therapy in bipolar disorder in adults.

GNH USA supplies Lamotrigine Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lamotrigine is an anticonvulsant indicated for several seizure types and mood stabilization in bipolar disorder.

Epilepsy (partial seizures): reduces the frequency and severity of focal seizures. Generalized tonic‑clonic seizures: helps control convulsive episodes. Bipolar disorder (maintenance therapy): stabilizes mood and helps prevent relapse of manic or depressive episodes.

Lamotrigine may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Dizziness or light‑headedness. - Headache. - Nausea or gastrointestinal upset. - Skin rash, often mild. - Blurred vision. - Insomnia or sleep disturbances.

Serious or Rare Side Effects: - Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Severe skin reactions such as drug reaction with eosinophilia and systemic symptoms (DRESS). - Blood dyscrasias including aplastic anemia or agranulocytosis. - Hepatic failure. - Suicidal thoughts or behavior. - Severe hypersensitivity reactions.

When prescribing lamotrigine, clinicians should consider several safety measures.

Dose titration: increase gradually to lower the risk of rash. Pregnancy: discuss limited data and weigh benefits against potential risks. Renal impairment: assess renal function and adjust dose if necessary. Concomitant valproate: monitor serum lamotrigine levels due to increased exposure. Avoid abrupt discontinuation: sudden stop may precipitate seizure recurrence. Store at ambient temperature: keep in the original container, protect from moisture and light.

Lamotrigine interacts with several medicines that can alter its plasma concentration or increase toxicity.

Major Interactions (Avoid): - Valproic acid: raises lamotrigine levels, heightening toxicity risk. - Carbamazepine: lowers lamotrigine concentrations, reducing efficacy. - Phenobarbital: decreases lamotrigine levels, potentially leading to breakthrough seizures.

Moderate Interactions (Monitor Closely): - Oral contraceptives: may reduce lamotrigine levels; dose adjustments may be required. - Serotonergic agents: monitor for signs of serotonin syndrome. - Other antiepileptics: combined therapy may necessitate serum level monitoring and dose modifications.